B. Corcoran

发表

Radiation precautions for inpatient and outpatient 177Lu-DOTATATE peptide receptor radionuclide therapy of neuroendocrine tumours

N. Mulholland, G. Vivian, D. Levart, 2019, EJNMMI Physics.

Title: Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation positive lung cancer

E. Collisson, F. Kaye, Wei Wu, 2019 .

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

M. T. Pellecchia, E. Rabiner, R. Gunn, 2019, The Lancet Neurology.

Application of an isocratic methanol-based HPLC method for the determination of iohexol concentrations and glomerular filtration rate in patients with cirrhosis

K. Moore, B. Corcoran, A. Slack, 2014, Annals of clinical biochemistry.

Long-term outcomes of 131Iodine mIBG therapy in metastatic gastrointestinal pancreatic neuroendocrine tumours: single administration predicts non-responders

Riddhika Chakravartty, N. Mulholland, G. Vivian, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence

J. Ramage, R. Srirajaskanthan, O. Wendler, 2020, Nuclear medicine communications.

The Role of Bone Scintigraphy with SPECT/CT in the Characterization and Early Diagnosis of Stage 0 Charcot Neuroarthropathy

M. Edmonds, N. Mulholland, G. Vivian, 2020, Journal of clinical medicine.

Metastatic malignancy mimics: a rare case of traumatic splenosis mimicking intra-abdominal malignancy

G. Vivian, B. Corcoran, L. Davis, 2020, BMJ Case Reports.

Clinical Non-Motor Phenotyping of Black and Asian Minority Ethnic Compared to White Individuals with Parkinson's Disease Living in the United Kingdom.

D. Aarsland, P. Martínez-Martín, A. Schrag, 2020, Journal of Parkinson's disease.

Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients

D. Brooks, P. Piccini, M. Politis, 2017, Movement disorders : official journal of the Movement Disorder Society.

Musculoskeletal pain in Parkinson's disease: Association with dopaminergic deficiency in the caudate nucleus

Silvia Rota, Kit Wu, A. Rizos, 2023, European journal of pain.

177Lu-Dotatate therapy for the treatment of metastatic neuroendocrine tumours in a patient on haemodialysis—dosimetric considerations

N. Mulholland, G. Vivian, E. Kalogianni, 2015, BJR case reports.